DOET

1. 2026-10-19issueIssued emergency
2. 2026-10-19issueIssued info_card
3. 2026-10-19issueIssued notice
4. 2026-09-07srcAltered free associations: Some cognitive effects of DOET (2,5-dimethoxy-4-ethylamphetamine)
5. 2026-09-07srcThe origin of 2,5-dimethoxy-4-methylamphetamine (DOM, STP)
6. 2026-09-07src5HT-2 mediation of acute behavioral effects of hallucinogens in rats.
7. 2026-09-07srcThe serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen.
8. 2026-09-07srcLC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum
9. 2026-09-07srcChronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans.
10. 2026-09-07srcRole of the 5-HT2A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice
11. 2026-09-07src2,5-Dimethoxyamphetamine-derived designer drugs: studies on the identification of cytochrome P450 (CYP) isoenzymes involved in formation of their main metabolites and on their capability to inhibit CYP2D6.
12. 2026-09-07srcSerotonergic hallucinogens as translational models relevant to schizophrenia.
13. 2026-09-07srcTolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice
14. 2026-09-07src1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents - A Review.
15. 2026-09-07srcDOM (STP), a New Hallucinogenic Drug, and DOET: Effects in Normal Subjects
16. 2026-09-07srcPsychedelics and the human receptorome
17. 2026-09-07srcBinding and functional structure-activity similarities of 4-substituted 2,5-dimethoxyphenyl isopropylamine analogues at 5-HT2A and 5-HT2B serotonin receptors.
18. 2026-09-07srcEntactogens: How the Name for a Novel Class of Psychoactive Agents Originated
19. 2026-09-07srcThe effects of 2,5-dimethoxy-4-methylamphetamine (DOM), 2,5-dimethoxy-4-ethylamphetamine (DOET), d-amphetamine, and cocaine in rats trained with mescaline as a discriminative stimulus.
20. 2026-09-07srcDifferences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT2A and 5-HT2C receptors.
21. 2026-09-07srcTranscriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex.
22. 2026-09-07srcSome pharmacological actions of 2,5-dimethoxy-4-ethylamphetamine (DOET) in rats and mice.
23. 2026-09-07srcRadioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
24. 2026-09-07srcStereospecific actions of DOET (2,5-dimethoxy-4-ethylamphetamine) in man.
25. 2026-09-07srcDOET (2,5-dimethoxy-4-ethylamphetamine), a new psychotropic drug. Effects of varying doses in man.
26. 2026-09-07srcEvidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
27. 2026-09-07srcSulfur analogues of psychotomimetic agents. 2. Analogues of (2,5-dimethoxy-4-methylphenyl)- and (2,5-dimethoxy-4-ethylphenyl)isopropylamine.
28. 2026-09-07srcComparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors.
29. 2026-09-07srcPiHKAL #66: DOET
30. 2026-09-07srcDEA Orange Book: Alphabetical Listing of Controlled Substances
31. 2026-09-07srcConvention on Psychotropic Substances 1971 - Schedule I
32. 2026-09-04issueIssued emergency
33. 2026-09-04issueIssued info_card
34. 2026-09-04issueIssued notice
35. 2026-06-04proposal28 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
36. 2026-06-04publicationPublication — backfill
37. 2026-05-09revisionRevision 1
38. 2026-05-09absenceSearched ClinicalTrials.gov for "DOET 2,5-dimethoxy-4-ethylamphetamine" — no results
39. 2026-05-09genGeneration — pipeline-v5 · with 15 morepipeline-v5
40. 2026-05-09rungeneration run

The same entries, as forms: six forms.